Cardiovascular Topics in Liver Transplantation


SIG Summary

The  Cardiovascular Special Interest Group was created with the aim of furthering the knowledge about pathophysiology, diagnosis, prevention and treatment of conditions that simultaneously affect the liver and the heart. The ultimate goal of this SIG is improving cardiovascular outcomes in patients with liver disease. The current Topic Coordinators and Steering Committee are all liver transplant professionals with extensive prior experience in one or all of these fields:


Topic Coordinators:

Manhal Izzy, Vanderbilt University, Nashville, TN, USA

Lisa VanWagner, Northwestern University, Chicago, IL, USA

Steering Committee members:

Mario Altieri, Caen, France

Ryan Chadha, Mayo Clinic, Jacksonville, FL, USA

James Findlay, Mayo Clinic, Rochester, MN, USA

John Klinck, Cambridge UK

Samuel Lee, Calgary, Canada

Kymberly Watt, Mayo Clinic, Rochester, MN, USA

Chris Wray, UCLA, Los Angeles, CA, USA

SIG Aims and Proposed Activities:

  1. Broadening knowledge of disease pathophysiology, diagnosis and management of: cirrhotic cardiomyopathy, cardiovascular disease in high risk populations such as those with NAFLD and Fontan-associated liver disease, cardiovascular risk stratification prior to liver transplantation, and long term cardiovascular outcomes after liver transplantation.
  2. Fostering collaborations in basic and translational/clinical studies of cardiovascular diseases in liver patients.
  3. Providing a platform for collaboration with related societies including but not limited to the American Heart Association, American Association for the Study of Liver Diseases, European Association for the study of the liver.
  4. Tailoring educational needs for each member across the novice to expert spectrum using on-line educational series, webinars, annual meetings and workshops.
  5. Retaining active and motivated members by offering additional opportunities to serve in leadership positions within ILTS through development of subcommittees and workgroups.
  6. Increasing membership within ILTS by attracting non-liver specialists interested in multidisciplinary collaboration within the sphere of cardiovascular diseases in liver patients.
  7. Establishing networking opportunities through in-person meetings at the ILTS annual meeting.

The Cardiovascular Special Interest Group is open to any member of the ILTS, and we encourage all members with special interest in one or all of these exciting and rapidly advancing fields to join.